EU regulator rejects Alzheimer's drug lecanemab Health Previous Article Study finds targeting inflammation may not help reduce liver fibrosis in MAFLD Next Article Recent insights and advances in treatment and management show promise in stemming the growing prevalence of diabetes It said the benefits of the treatment did not outweigh the risk of serious side effects....Read more https://www.bbc.com/news/articles/crgm0v1ne08o Previous Article Study finds targeting inflammation may not help reduce liver fibrosis in MAFLD Next Article Recent insights and advances in treatment and management show promise in stemming the growing prevalence of diabetes